tiprankstipranks
Trending News
More News >
Polaris (PII)
NYSE:PII
US Market
Advertisement

Polaris (PII) Drug Pipeline

Compare
1,000 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Adi-Peg20
Nonalcoholic Steatohepatitis (Nash)
Phase II
Recruiting
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
Jan 20, 2023
Adi Peg20
Soft Tissue Sarcoma
Phase III
Recruiting
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Dec 13, 2022
Adi-Peg20
Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma
Phase III
Recruiting
Study of ADI-PEG 20 Versus Placebo in Subjects with High Arginine Level and Unresectable Hepatocellular Carcinoma
Apr 01, 2022
Temozolomide, Adi-Peg 20
Glioblastoma Multiforme (Gbm)
Phase II
Active Not Recruiting
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
Sep 04, 2020

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Polaris (PII) have in its pipeline
      PII is currently developing the following drugs: Adi-Peg20, Adi Peg20, Adi-Peg20. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis